• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腮腺恶性上皮性肿瘤的预后变量

Prognostic variables in malignant epithelial tumors of the parotid.

作者信息

Poulsen M G, Pratt G R, Kynaston B, Tripcony L B

机构信息

Queensland Radium Institute, Herston, Brisbane, Australia.

出版信息

Int J Radiat Oncol Biol Phys. 1992;23(2):327-32. doi: 10.1016/0360-3016(92)90749-8.

DOI:10.1016/0360-3016(92)90749-8
PMID:1316888
Abstract

A retrospective analysis was performed on 209 patients with carcinoma of the parotid who were treated with curative intent using surgery and post-operative irradiation. The five and ten-year actuarial survival were 71% and 65%. Failure at the primary site occurred in 24%, at nodal sites in 14%, and distantly in 23%. Multivariate analysis of prognostic variables identified age greater than 60 years, involved nodes, post-surgical residual disease, and poor differentiation to be bad prognostic variables.

摘要

对209例接受了根治性手术及术后放疗的腮腺癌患者进行了回顾性分析。5年和10年精算生存率分别为71%和65%。原发部位失败率为24%,淋巴结部位为14%,远处转移为23%。对预后变量的多因素分析确定年龄大于60岁、有淋巴结受累、术后残留疾病以及低分化为不良预后变量。

相似文献

1
Prognostic variables in malignant epithelial tumors of the parotid.腮腺恶性上皮性肿瘤的预后变量
Int J Radiat Oncol Biol Phys. 1992;23(2):327-32. doi: 10.1016/0360-3016(92)90749-8.
2
[Electron therapy of malignant parotid tumors].[恶性腮腺肿瘤的电子线治疗]
Strahlenther Onkol. 1988 Mar;164(3):136-40.
3
[Results of photon therapy of malignant tumors of the parotid gland].
Strahlenther Onkol. 1992 Jun;168(6):311-7.
4
[Clinical and histological experiences in 54 malignant parotid tumors].
Langenbecks Arch Chir. 1971;330(1):45-53. doi: 10.1007/BF01230641.
5
Malignant epithelial tumors of the parotid gland. Classification, staging and treatment.腮腺恶性上皮性肿瘤。分类、分期及治疗
Arch Chir Neerl. 1973;25(4):441-56.
6
Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes.腮腺恶性肿瘤:临床表现、临床/病理预后因素及治疗结果
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):112-8. doi: 10.1016/j.ijrobp.2004.04.052.
7
Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.丹尼尔·丹霍德癌症中心 186 例原发性腮腺癌患者手术联合放疗的长期疗效及生活质量。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):189-95. doi: 10.1016/j.ijrobp.2011.11.045. Epub 2012 Feb 11.
8
High-grade malignancies of the parotid gland: effective use of planned combined surgery and irradiation.腮腺高级别恶性肿瘤:计划性联合手术与放疗的有效应用。
Laryngoscope. 1985 Sep;95(9 Pt 1):1059-63.
9
[Primary carcinoma of the parotid gland. A retrospective study of 31 cases].
Rev Stomatol Chir Maxillofac. 1995;96(5):310-2.
10
Prognostic Factors and Clinical Outcome in Parotid Gland Tumors: a Single Institution Experience from the Eastern Black Sea Region of Turkey.腮腺肿瘤的预后因素及临床结局:来自土耳其黑海东部地区一家机构的经验
Asian Pac J Cancer Prev. 2016;17(3):1169-74. doi: 10.7314/apjcp.2016.17.3.1169.

引用本文的文献

1
Primary parotid carcinoma: analysis of risk factors and validation of a prognostic index.原发性腮腺癌:危险因素分析及预后指数验证
Eur Arch Otorhinolaryngol. 2018 Nov;275(11):2829-2841. doi: 10.1007/s00405-018-5122-1. Epub 2018 Sep 12.
2
Parotid carcinoma: Current diagnostic workup and treatment.腮腺癌:当前的诊断检查与治疗
Indian J Surg Oncol. 2010 Apr;1(2):96-111. doi: 10.1007/s13193-010-0022-x. Epub 2010 Nov 21.
3
An audit of surgery of the parotid gland.腮腺手术审计
Ann R Coll Surg Engl. 1995 May;77(3):188-92.